Pfizer CEO Albert Bourla sits down with CNBC’s Meg Tirrell and the ‘Squawk Box’ team to discuss the company’s Covid-19 vaccine booster strategy, including a potential shot targeting the omicron variant.
Advertisement
(function(w,d,s,i){w.ldAdInit=w.ldAdInit||[];w.ldAdInit.push({slot:13348268193035366,size:[0, 0],id:"ld-4546-3812"});if(!d.getElementById(i)){var j=d.createElement(s),p=d.getElementsByTagName(s)[0];j.async=true;j.src="//cdn2.lockerdomecdn.com/_js/ajs.js";j.id=i;p.parentNode.insertBefore(j,p);}})(window,document,"script","ld-ajs");